| Filed | Form | Description | |
|---|---|---|---|
| 7/16/25 | DEF 14A | DEF 14A | → |
| 6/20/24 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 5/31/23 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 6/2/22 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 7/28/21 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 7/16/21 | PRE 14A | PRELIMINARY PROXY STATEMENT | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/29/26 | 4 | 4 | → |
| 1/29/26 | 4 | 4 | → |
| 1/29/26 | 4 | 4 | → |
| 1/29/26 | 4 | 4 | → |
| 1/21/26 | 4 | 4 | → |
| 1/5/26 | 4 | 4 | → |
| ↓ | |||
, is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem.